MEDI CAPS Latest Share Price (MEDICAPQ)
TODAY IN ONE LINE
MEDICAPQ dropped 3.4%, lagging Nifty's 0.0% move, supported by recent strong earnings.
it trades at a P/E of N/A. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
MEDI CAPS flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●High Promoter HoldingPromoters hold 51.4% skin-in-the-game
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.00x
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
No red flags identified
Latest MEDI CAPS News
What changed recently?
Recent events, corporate actions, and announcements.
MEDI CAPS valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for MEDI CAPS, framed against the sector median so the premium or discount is obvious at a glance.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
MEDI CAPS technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for MEDI CAPS — derived from the latest tape, not yesterday's close.
MEDI CAPS last traded at ₹24.94 with an intraday range of ₹24.52–₹25.8 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹24.94| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 28.21 | +3.27 | +13.12% |
| R3 | 26.93 | +1.99 | +7.99% |
| R2 | 26.37 | +1.43 | +5.72% |
| R1 | 25.65 | +0.71 | +2.86% |
| PIVOT | 25.09 | 0.15 | 0.59% |
| CURRENT | 24.94 | — | — |
| S1 | 24.37 | -0.57 | -2.27% |
| S2 | 23.81 | -1.13 | -4.54% |
| S3 | 23.09 | -1.85 | -7.40% |
| S4 | 21.81 | -3.13 | -12.54% |
MEDICAPQ is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹25.5–₹25.8
Trading Below opening range, showing Bearishness
MEDI CAPS financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for MEDI CAPS — consolidated or standalone — with margins, YoY growth and key ratios inline.
MEDI CAPS reports its full P&L, balance sheet, cash flow and ratios on this page — current reported EPS of ₹-1.79.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue from Operations | 25 | 12 ▼ 51.1% |
| Sales Growth YoY %Derived | -6.83% | -51.14% |
| Other Income | 3 | 8 ▲ 200.7% |
| Total Income | 28 | 21 ▼ 26.8% |
| 11 | 6 ▼ 47.1% | |
| Gross ProfitDerived | 15 | 7 ▼ 54.1% |
| Gross Margin %Derived | 58.19% | 54.70% |
| 17 | 16 ▼ 2.6% | |
| EBITDA (Operating Profit)Derived | -2 | -9 ▼ 414.9% |
| OPM %Derived | -7.17% | -75.59% |
| 2 | 2 ▲ 4.5% | |
| Profit Before Tax (PBT) | -1 | -3 ▼ 259.5% |
| -0 | 0 ▲ 105.2% | |
| Effective Tax %Derived | 32.11% | -0.47% |
| Profit/Loss from Discontinued Ops | — | — |
| Total Profit for Period | -1 | -3 ▼ 432.0% |
| Net Profit (Owner's PAT)Derived | -1 | -3 ▼ 432.0% |
| Net Profit Margin %Derived | -2.24% | -24.40% |
| PAT Growth YoY %Derived | 74.52% | -431.96% |
| Earnings Per Share (EPS ₹) | -0.46 | -2.44 ▼ 430.4% |
| Diluted Shares Outstanding (Cr) | 1 | 1 ▲ 0.0% |
| Other Comprehensive Income (Net of Tax) | 1 | -7 ▼ 866.8% |
| Total Expenses (incl. D&A & Interest) | 29 | 24 ▼ 18.5% |
| Material Cost % of RevenueDerived | 39.92% | 43.69% |
| Employee Cost % of RevenueDerived | 29.77% | 62.21% |
| Other Cost % of RevenueDerived | 35.60% | 68.08% |
| Interest Coverage (x)Derived | -142.98x | -862.95x |
| Period | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Trend |
|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 54 | 45 ▼ 15.9% | 59 ▲ 29.5% | 70 ▲ 19.0% | 49 ▼ 29.3% | 27 ▼ 44.6% | 25 ▼ 6.8% | 12 ▼ 51.1% | |
| Sales Growth YoY %Derived | — | -15.94% | 29.55% | 18.99% | -29.34% | -44.61% | -6.83% | -51.14% | |
| Other Income | 1 | 1 ▲ 1.9% | 1 ▼ 1.9% | 2 ▲ 227.9% | 2 ▼ 16.2% | 0 ▼ 70.4% | 3 ▲ 474.6% | 8 ▲ 200.7% | |
| Total Income | 55 | 46 ▼ 15.7% | 59 ▲ 29.1% | 72 ▲ 21.0% | 51 ▼ 29.0% | 28 ▼ 45.4% | 28 ▲ 1.4% | 21 ▼ 26.8% | |
26 | 27 ▲ 1.8% | 29 ▲ 9.5% | 30 ▲ 2.5% | 23 ▼ 23.9% | 10 ▼ 58.4% | 11 ▲ 11.9% | 6 ▼ 47.1% | ||
| Gross ProfitDerived | 28 | 19 ▼ 32.9% | 29 ▲ 58.7% | 40 ▲ 35.4% | 26 ▼ 33.4% | 18 ▼ 32.6% | 15 ▼ 16.8% | 7 ▼ 54.1% | |
| Gross Margin %Derived | 51.14% | 40.82% | 49.99% | 56.91% | 53.61% | 65.19% | 58.19% | 54.70% | |
21 | 23 ▲ 10.9% | 17 ▼ 25.6% | 30 ▲ 73.5% | 21 ▼ 28.2% | 18 ▼ 16.5% | 17 ▼ 6.8% | 16 ▼ 2.6% | ||
| EBITDA (Operating Profit)Derived | 7 | -5 ▼ 168.0% | 12 ▲ 365.2% | 10 ▼ 18.2% | 5 ▼ 49.2% | -0 ▼ 100.7% | -2 ▼ 5197.4% | -9 ▼ 414.9% | |
| OPM %Derived | 12.52% | -10.13% | 20.74% | 14.25% | 10.25% | -0.13% | -7.17% | -75.59% | |
2 | 2 ▲ 1.0% | 2 ▼ 17.6% | 2 ▲ 19.2% | 2 ▼ 3.8% | 2 ▼ 3.3% | 2 ▲ 3.4% | 2 ▲ 4.5% | ||
| Profit Before Tax (PBT) | 6 | -6 ▼ 206.2% | 11 ▲ 292.3% | 10 ▼ 10.5% | 5 ▼ 51.1% | -1 ▼ 125.3% | -1 ▲ 32.5% | -3 ▼ 259.5% | |
0 | 0 ▼ 92.8% | -0 ▼ 160.7% | 0 ▲ 382.4% | 3 ▲ 21111.1% | 1 ▼ 67.4% | -0 ▼ 127.2% | 0 ▲ 105.2% | ||
| Effective Tax %Derived | 2.12% | -0.14% | -0.05% | 0.14% | 62.07% | -79.83% | 32.11% | -0.47% | |
| Profit/Loss from Discontinued Ops | — | — | -0 | 0 ▲ 132.1% | -0 ▼ 397.6% | — ▲ 100.0% | — | — | |
| Total Profit for Period | 5 | -6 ▼ 208.6% | 11 ▲ 290.2% | 10 ▼ 9.4% | 2 ▼ 82.6% | -2 ▼ 227.6% | -1 ▲ 74.5% | -3 ▼ 432.0% | |
| Net Profit (Owner's PAT)Derived | 5 | -6 ▼ 208.6% | 11 ▲ 290.2% | 10 ▼ 9.4% | 2 ▼ 82.6% | -2 ▼ 227.6% | -1 ▲ 74.5% | -3 ▼ 432.0% | |
| Net Profit Margin %Derived | 9.99% | -12.91% | 18.95% | 14.43% | 3.56% | -8.19% | -2.24% | -24.40% | |
| PAT Growth YoY %Derived | — | -208.63% | 290.18% | -9.42% | -82.58% | -227.63% | 74.52% | -431.96% | |
| Earnings Per Share (EPS ₹) | 4.32 | -4.69 ▼ 208.6% | 8.92 ▲ 290.2% | 8.08 ▼ 9.4% | 1.41 ▼ 82.5% | -1.80 ▼ 227.7% | -0.46 ▲ 74.4% | -2.44 ▼ 430.4% | |
| Diluted Shares Outstanding (Cr) | 1 | 1 ▲ 0.0% | 1 ▲ 0.0% | 1 ▲ 0.0% | 1 ▲ 0.0% | 1 ▲ 0.0% | 1 ▲ 0.0% | 1 ▲ 0.0% | |
| Other Comprehensive Income (Net of Tax) | — | 1 | 3 ▲ 118.5% | 1 ▼ 44.3% | 1 ▼ 61.8% | 5 ▲ 731.6% | 1 ▼ 81.4% | -7 ▼ 866.8% | |
| Total Expenses (incl. D&A & Interest) | 49 | 52 ▲ 5.6% | 48 ▼ 7.2% | 62 ▲ 28.4% | 46 ▼ 25.4% | 29 ▼ 36.9% | 29 ▼ 0.1% | 24 ▼ 18.5% | |
| Material Cost % of RevenueDerived | 48.82% | 49.26% | 52.92% | 43.00% | 44.67% | 30.82% | 39.92% | 43.69% | |
| Employee Cost % of RevenueDerived | 17.73% | 24.35% | 11.43% | 11.03% | 15.57% | 25.85% | 29.77% | 62.21% | |
| Other Cost % of RevenueDerived | 20.90% | 26.60% | 17.83% | 31.62% | 27.78% | 39.47% | 35.60% | 68.08% | |
| Interest Coverage (x)Derived | 274.29x | -379.99x | — | 40,718.00x | 2,074.44x | — | -142.98x | -862.95x |
MEDI CAPS segment analysis : revenue and profit mix.
Disclosed business segments at MEDI CAPS with their share of revenue and profit, switchable between consolidated and standalone reporting.
MEDI CAPS discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for MEDI CAPS.
Our AI distills the core fundamental drivers supporting MEDI CAPS, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
What you're getting.
No strengths or opportunities on record.
Key Risks.
No weaknesses or threats on record.
Flip Conditions.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
MEDI CAPS peer comparison — same-sector benchmarks.
No comparable peer set was disclosed for MEDI CAPS.
Peer comparison data is not available.
MEDI CAPS chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for MEDI CAPS — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
MEDI CAPS delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for MEDI CAPS over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in MEDI CAPS stood at 79.3% of traded volume, against a 20-day average of 77.5%.
MEDI CAPS announcements: results, concalls, ratings, M&A.
Filings MEDI CAPS sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
MEDI CAPS files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 36 documents below.
Company Update
Submission of News paper publication after dispatch of 43rd AGM Notice and Annual Report 2025-26.
AGM/EGM
Information under Regulation 44 of SEBI (LODR) Regulation, 2015 and Section 108 of Companies Act, 2013 regarding E-Voting through electronic mode for…
Company Update
Intimation for dispatch of letter to those shareholders whose email addresses are not registered with company/registrar & transfer agent/Depository…
Others
Submission of 43rd Annual Report for the Financial Year 2025-26 pursuant to Regulation 34 of SEBI (Listing Obligation and Disclosure Requirement)…
AGM/EGM
Submission of Notice of 43rd Annual General Meeting scheduled to be held on 22nd September, 2026 at 12:30 PM (IST) through Video Conference…
Investor decks & rating reports.
MEDI CAPS dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue MEDI CAPS has declared, sequenced by announce and record date.
MEDI CAPS corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About MEDI CAPS: business, sector, key facts.
What MEDI CAPS does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
MEDI CAPS is a listed Indian equity.
MEDI CAPS
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
Questions investors ask about MEDI CAPS (MEDICAPQ).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of MEDI CAPS (MEDICAPQ)?
The current share price of MEDI CAPS (MEDICAPQ) is ₹24.94. Today, the stock has declined by ₹0.87 (3.37%), trading in a range of ₹24.52 to ₹25.80. The stock opened at ₹25.80 with a trading volume of 8,599 shares.
02What is the 52-week high and low price of MEDI CAPS stock?
The 52-week high price of MEDI CAPS (MEDICAPQ) is ₹36.80, while the 52-week low is ₹20.33. Currently trading at ₹24.94, the stock is 22.68% above its 52-week low and 32.23% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
03What is the dividend yield of MEDI CAPS and when is the next dividend?
MEDI CAPS offers a dividend yield of 0%, which means for every ₹100 invested at the current price of ₹24.94, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
04How is MEDI CAPS stock performing today in the market?
MEDI CAPS stock opened at ₹25.80 and is currently trading at ₹24.94, showing a decline of ₹0.87 (3.37%). The intraday high is ₹25.80 and low is ₹24.52. The trading volume stands at 8,599 shares, indicating moderate market participation today.
05What is the market capitalization of MEDI CAPS?
MEDI CAPS has a market capitalization of ₹0, making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹24.94) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
06What is the ROE and ROCE of MEDI CAPS?
MEDI CAPS has a Return on Equity (ROE) of 0% and Return on Capital Employed (ROCE) of 0%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
07Which sector and industry does MEDI CAPS belong to?
MEDI CAPS operates in the broader sector and belongs to the its industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
08What is the sales and profit growth of MEDI CAPS?
MEDI CAPS has reported a sales growth of 0% and profit growth of -278.71%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
The data, ratios and commentary about MEDI CAPS (MEDICAPQ) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.